Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant987 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,216 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01659502 | Investigator's Initiated Phase II Study for Pancreatic Cancer Patients | unknown | Phase 2 | 10 | Tiltan Pharma Ltd.INDUSTRY | 1 | Dec 5, 2013 | clinicaltrials |
| NCT01994681 | Testing Spectrosense EVA System for Detection of Pancreatic Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air | unknown | — | 100 | Rauscher, Gregory E., M.D. PAINDIV | 1 | Dec 5, 2013 | clinicaltrials |
| NCT00005869 | Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | unknown | Phase 3 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005870 | Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas | unknown | Phase 3 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005871 | Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer | unknown | Phase 3 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT01978808 | Efficiency Study of the EUS-FNA Needles With and Without a Side Port in Pancreatic Masses | unknown | — | 200 | National Taiwan University HospitalOTHER | 1 | Nov 13, 2013 | clinicaltrials |
| NCT00454376 | Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors | unknown | — | 408 | National Cancer Institute (NCI)NIH | 10 | Oct 29, 2013 | clinicaltrials |
| NCT01969110 | Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy | unknown | Phase 4 | 60 | Chiba UniversityOTHER | 1 | Oct 25, 2013 | clinicaltrials |
| NCT01942629 | Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas | unknown | — | 300 | Rambam Health Care CampusOTHER | 0 | Sep 16, 2013 | clinicaltrials |
| NCT01931449 | Evaluation of A New Digestive Reconstruction Procedure Following Pancreatoduodenectomy | unknown | Phase 3 | 200 | Southwest Hospital, ChinaOTHER | 1 | Aug 29, 2013 | clinicaltrials |
| NCT00757614 | Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom | unknown | — | 14,000 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01919151 | Micrometastasis in Gastrointestinal Cancer | unknown | — | 500 | Oslo University HospitalOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01897636 | Efficacy and Safety of Endoscopic Ultrasound Guided Fine-needle Injection of Dendritic Cells Vaccination Into Unresectable Pancreatic Cancer(DC) | unknown | N/A | 30 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jul 12, 2013 | clinicaltrials |
| NCT01448668 | Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV) | unknown | — | 220 | IFAG AGINDUSTRY | 2 | Jul 2, 2013 | clinicaltrials |
| NCT01867892 | A Phase II Study of Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 86 | National Health Research Institutes, TaiwanOTHER | 0 | Jun 4, 2013 | clinicaltrials |
| NCT01819961 | Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery | unknown | Phase 4 | 50 | Wei ZhouOTHER | 1 | Mar 28, 2013 | clinicaltrials |
| NCT01811277 | SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer | unknown | Phase 2 | 40 | Peking UniversityOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT00639925 | Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer | unknown | Phase 1 | 5 | Fukushima Medical UniversityOTHER | 1 | Mar 14, 2013 | clinicaltrials |
| NCT01796782 | QYHJ Granules Versus Xeloda in Metastatic Pancreatic Cancer | unknown | Phase 2 | 60 | Fudan UniversityOTHER | 0 | Feb 22, 2013 | clinicaltrials |
| NCT01717196 | Diagnostic Accuracy of FNA: is Aspiration- Related?(expect fna) | unknown | N/A | 100 | The Mediterranean Institute for Transplantation and Advanced Specialized TherapiesOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT01717807 | C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR).(EGFR; PET/CT) | unknown | — | 30 | Hadassah Medical OrganizationOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01675258 | Identifying Saliva Markers of Patients With Stomach, Colorectal (Including Pre-cancer Polyp) and Pancreatic Cancers | unknown | — | 150 | Hadassah Medical OrganizationOTHER | 1 | Aug 29, 2012 | clinicaltrials |
| NCT01665625 | Regional Versus Systemic Chemotherapy in the Treatment of Unresectable Pancreatic Cancer | unknown | N/A | 90 | Air Force Military Medical University, ChinaOTHER | 1 | Aug 15, 2012 | clinicaltrials |
| NCT01641003 | Isolation and Characterization of Cancer Stem Cells Using iFP Technique | unknown | — | 15 | Rambam Health Care CampusOTHER | 1 | Jul 16, 2012 | clinicaltrials |
| NCT00440167 | Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine | unknown | Phase 3 | 280 | PD Dr. med. Volker HeinemannOTHER | 0 | Jul 9, 2012 | clinicaltrials |
| NCT00658840 | Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic Carcinoma | unknown | Phase 2 | 55 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 3, 2012 | clinicaltrials |
| NCT00082862 | Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer | unknown | Phase 2 | 48 | The University of Texas Health Science Center, HoustonOTHER | 1 | Feb 13, 2012 | clinicaltrials |
| NCT00855985 | Anastomotic Techniques in Pancreaticoduodenectomy(PG/PJ) | unknown | N/A | 312 | Lakeshore HospitalOTHER | 1 | Sep 27, 2011 | clinicaltrials |
| NCT00795977 | Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 20 | Fukushima Medical UniversityOTHER | 1 | Sep 8, 2011 | clinicaltrials |
| NCT01372735 | Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer(NEOPANC) | unknown | Phase 1 / Phase 2 | 46 | University Hospital HeidelbergOTHER | 1 | Jun 14, 2011 | clinicaltrials |
| NCT01333631 | Valproic Acid With Chemoradiotherapy for Pancreatic Cancer | unknown | Phase 2 | 20 | Soroka University Medical CenterOTHER | 0 | Apr 12, 2011 | clinicaltrials |
| NCT01324856 | Pancreaticogastrostomy Versus Pancreaticojejunostomy in Reconstruction After Cephalic Duodenopancreatectomy(PanAm) | unknown | Phase 1 | 100 | University of BelgradeOTHER | 1 | Apr 11, 2011 | clinicaltrials |
| NCT01333332 | Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer | unknown | Phase 2 | 35 | University of VirginiaOTHER | 1 | Apr 11, 2011 | clinicaltrials |
| NCT00178763 | Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer(FR-WB-TT) | unknown | Phase 2 | 36 | The University of Texas Health Science Center, HoustonOTHER | 1 | Mar 3, 2011 | clinicaltrials |
| NCT01266720 | HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1) | unknown | Phase 1 | 6 | Fukushima Medical UniversityOTHER | 1 | Dec 24, 2010 | clinicaltrials |
| NCT01219192 | Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure | unknown | Phase 1 | 24 | Beijing Protgen Biotechnology Development Co., Ltd.INDUSTRY | 1 | Oct 28, 2010 | clinicaltrials |
| NCT01218880 | Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer | unknown | Phase 1 | 21 | Beijing Protgen Biotechnology Development Co., Ltd.INDUSTRY | 1 | Oct 19, 2010 | clinicaltrials |
| NCT00551057 | Expression of Inflammatory Proteins in Pancreatic Cancer | unknown | — | 150 | University of ZurichOTHER | 1 | Sep 17, 2010 | clinicaltrials |
| NCT01182831 | Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas | unknown | Phase 1 | 100 | Asian Institute of Gastroenterology, IndiaOTHER | 1 | Aug 30, 2010 | clinicaltrials |
| NCT01127815 | Identify the Clinical Significance and Potential Implications of Peritoneal Washing Cytology (PWC) in Patients With Pancreatic Cancer | unknown | — | 300 | National Taiwan University HospitalOTHER | 0 | May 21, 2010 | clinicaltrials |
| NCT00690300 | Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer | unknown | Phase 2 | 44 | University of UlmOTHER | 1 | Mar 3, 2010 | clinicaltrials |
| NCT01063192 | A Study of Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 73 | National Health Research Institutes, TaiwanOTHER | 0 | Feb 5, 2010 | clinicaltrials |
| NCT00915863 | Evaluation of Isolated Roux-en-Y Reconstruction After Pancreaticoduodenectomy | unknown | N/A | 150 | Wakayama Medical UniversityOTHER | 1 | Jan 26, 2010 | clinicaltrials |
| NCT00947102 | Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer(GEMSTHER) | unknown | — | — | Blood Transfusion Centre of SloveniaOTHER_GOV | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00541021 | Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | unknown | Phase 3 | 104 | Institut Paoli-CalmettesOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00006117 | Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Oct 30, 2009 | clinicaltrials |
| NCT00906802 | Benefit of Roux-en-Y (R-Y) Reconstruction After Pancreaticoduodenectomy | unknown | N/A | 40 | Kochi UniversityOTHER | 1 | Jul 23, 2009 | clinicaltrials |
| NCT00683358 | Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | May 7, 2009 | clinicaltrials |
Data updated 22 days agoSource updated Dec 5, 2013source: clinicaltrials